Pancreatic Cancer Research

ResearcherYamaguchi UniversityActive in the last 2 years

Shogo Amano

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4487-2420; OpenAlex author ID A5084841968. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
18
Papers, trials and grants by year

2018: 2 papers · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 2 papers · 2024: 1 paper

Papers 7

  1. [Our Experience of Staging Laparoscopy for Patients with Pancreatic Cancer before Initial Treatment]. Co-author PMID 39948962↗
  2. Correction: Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox. Co-author DOI 10.1186/s12885-023-11091-y↗
  3. Retraction Note: Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox. Co-author DOI 10.1186/s12885-023-11677-6↗
  4. CA19-9 in Combination with Methylated HOXA1 and SST Is Useful to Diagnose Stage I Pancreatic Cancer. Co-author DOI 10.1159/000527342↗
  5. Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox. Co-author DOI 10.1186/s12885-020-07167-8↗
  6. Deferasirox, an oral iron chelator, with gemcitabine synergistically inhibits pancreatic cancer cell growth in vitro and in vivo. Co-author DOI 10.18632/oncotarget.25421↗
  7. Heat Shock Protein 27 Expression in EUS-FNA Samples Can Predict Gemcitabine Sensitivity in Pancreatic Cancer. Co-author DOI 10.21873/invivo.11286↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Isao Sakaida · 6 shared papers, 2018–2023 · strength 0.75
  2. Taro Takami · 5 shared papers, 2018–2023 · strength 0.66
  3. Takahiro Yamasaki · 5 shared papers, 2018–2023 · strength 0.66
  4. Shuhei Shinoda · 5 shared papers, 2018–2023 · strength 0.63
  5. Hirofumi Harima · 4 shared papers, 2018–2023 · strength 0.54
  6. Manabu Sen-yo · 2 shared papers, 2018–2024 · strength 0.27
  7. Shigeyuki Suenaga · 2 shared papers, 2018–2022 · strength 0.21
  8. Masaki Iwado · 1 shared paper, 2024 · strength 0.18
  9. Shigeru Yamamoto · 1 shared paper, 2024 · strength 0.18
  10. Satoshi Matsukuma · 1 shared paper, 2024 · strength 0.18
  11. Kaori Hamamoto · 1 shared paper, 2022 · strength 0.12
  12. Yuko Fujimoto · 1 shared paper, 2022 · strength 0.12
  13. Hiroaki Nagano · 1 shared paper, 2022 · strength 0.12
  14. Keiko Shinjo · 1 shared paper, 2022 · strength 0.12
  15. Yutaka Suehiro · 1 shared paper, 2022 · strength 0.12
  16. Hiroto Matsui Matsui · 1 shared paper, 2022 · strength 0.12
  17. Yutaka Kondo · 1 shared paper, 2022 · strength 0.12
  18. Michitaka Kawano · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.